| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/2009 | CN101448499A Use of cantffln-6-ketone and its analogues in the treatment of pathologies linked to mycobacteria |
| 06/03/2009 | CN101448498A Compositions of R(+) and S(-) pramipexole and methods of using the same |
| 06/03/2009 | CN101448497A Viral hepatitis treatment |
| 06/03/2009 | CN101448496A Method of treatment of hereditary hemochromatosis |
| 06/03/2009 | CN101448495A Benzimidazoles which have activity at M1 receptor and their uses in medicine |
| 06/03/2009 | CN101448493A Duloxetine hydrochloride delayed release formulations |
| 06/03/2009 | CN101448492A Methods for treating cognitive and other disorders |
| 06/03/2009 | CN101448491A A pharmaceutical composition containing lactates and calcium |
| 06/03/2009 | CN101448490A Method of treatment of chronic nonbacterial prostatitis with selective estrogen receptor modulators or aromatase inhibitors |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101445494A Conjugated psychotropic drugs and uses thereof |
| 06/03/2009 | CN101445493A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/03/2009 | CN101444528A GIP secretion inhibitor |
| 06/03/2009 | CN101444527A Medicament for curing oral ulcer |
| 06/03/2009 | CN101444526A Pharmaceutical composition |
| 06/03/2009 | CN101444525A RNAi-mediated inhibition of ocular targets |
| 06/03/2009 | CN101444524A New applications of cytidine diphosphate in treating ischemic diseases |
| 06/03/2009 | CN101444523A Application of pueraria flower glucoside in preparation of medical compound for remedying osteoporosis |
| 06/03/2009 | CN101444522A Application of algin oligosaccharide |
| 06/03/2009 | CN101444521A Pharmaceutical preparation containing alendronate sodium and cholecalciferol-cholesterol |
| 06/03/2009 | CN101444520A Application of progesterones in preparing medicament for curing severe stroke and brain injury |
| 06/03/2009 | CN101444519A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 06/03/2009 | CN101444518A Use of ursolic acid in preparing immunomodulator |
| 06/03/2009 | CN101444517A Use of ursolic acid in preparing medicine capable of restraining neoplasm metastatis |
| 06/03/2009 | CN101444516A Use of ursolic acid in preparing medicine capable of regulating and controlling tumour cell division cycle |
| 06/03/2009 | CN101444515A Use of ursolic acid in preparing medicine capable of inducing apoptosis of tumour cell |
| 06/03/2009 | CN101444514A Cefmenoxime hydrochloride preparation for injection and preparation method thereof |
| 06/03/2009 | CN101444513A Cefaclor orally disintegrating tablet and preparation method thereof |
| 06/03/2009 | CN101444512A Application of terazosin for preparing medicines for treating postpartum urinary retention |
| 06/03/2009 | CN101444511A Low dose entecavir formulation and use |
| 06/03/2009 | CN101444510A Pharmaceutical preparation containing Voriconazole and preparation method thereof |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN101444508A Tropisetron preparation for injection and preparation method thereof |
| 06/03/2009 | CN101444507A Pharmaceutical composition for treating type 2 diabetes |
| 06/03/2009 | CN101444506A Application of rapamycin in preparing medicines for treating addiction to morphine-like drugs |
| 06/03/2009 | CN101444505A Feverfew lactone coating tablet |
| 06/03/2009 | CN101444504A Feverfew lactone dripping pill |
| 06/03/2009 | CN101444503A Efficient long-acting silibinin preparation and preparation method thereof |
| 06/03/2009 | CN101444502A A high-purity tea polyphenol buccal tablets and preparation method thereof |
| 06/03/2009 | CN101444501A Application of mother-nucleus conjugated iridoid in preparing anti-tumor medicine |
| 06/03/2009 | CN101444500A Application of iridoid in preparing anti-tumor medicine |
| 06/03/2009 | CN101444499A Compound and new usage of composition thereof |
| 06/03/2009 | CN101444498A Use of retigabine or its medical salts for the treatment of neuropathic pain |
| 06/03/2009 | CN101444497A Salvia miltiorrhiza danshinolic acid A and the application of a medicine composition containing salvia miltiorrhiza danshinolic acid A |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN101444470A Use of oligosaccharides to stimulate beta-endorphin production |
| 06/03/2009 | CN100495028C A process for the isolation of a major harmful oxidant from cigarette smoke |
| 06/03/2009 | CN100494398C Method of determining glutachione-S-transferase pi expression |
| 06/03/2009 | CN100494212C Indolopyrrolocabazole derivative and antitumor agent |
| 06/03/2009 | CN100494205C Phosphorylated glyceryl ether aluminium salts |
| 06/03/2009 | CN100494202C Spirofuropyridine aryl derivatives |
| 06/03/2009 | CN100494190C Compound containing o-naphthaquinone and application |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100494180C Preparation method and uses of isoquinolinium compound and its salt |
| 06/03/2009 | CN100494175C Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
| 06/03/2009 | CN100493614C Anticancer medicine-chitosan complex for forming self-aggregates and preparation method thereof |
| 06/03/2009 | CN100493613C A method to improve surface properties of pharmaceutical tablets |
| 06/03/2009 | CN100493609C Medicine composition for treating malignant tumours and application |
| 06/03/2009 | CN100493568C Rhizome Anemarrhenae total saponin and its preparation method |
| 06/03/2009 | CN100493519C Preparation method for liquid for preventing conglutination in the surgery |
| 06/03/2009 | CN100493518C A blood fat-decreasing traditional Chinese medicine and preparation method thereof |
| 06/03/2009 | CN100493517C Vitamin dripping pill and its preparing method |
| 06/03/2009 | CN100493516C Clorfarabine composition |
| 06/03/2009 | CN100493515C Nano emulsion containing ginsenoside, preparation method and usage |
| 06/03/2009 | CN100493514C Composite medicine of creatine phosphate sodium and magnesium salt |
| 06/03/2009 | CN100493513C Application of 4-de-dimethyltetracycline derivative |
| 06/03/2009 | CN100493512C Slow-released preparation containing hydrochlorothiazide and clonidine hydrochloride and its preparing method |
| 06/03/2009 | CN100493511C Tablets of vacyclovir hydrochloride, and its preparing method |
| 06/03/2009 | CN100493510C Application of compound 6-furfuryl amino purine in preparing medicine for treating myocardial tissue oxidizing damage |
| 06/03/2009 | CN100493509C Application of compound 6-furfuryl amino purine in preparing medicine for treating testis senility |
| 06/03/2009 | CN100493508C Application of compound 6-furfuryl amino purine in preparing medicine for treating myocardial ischemia damage |
| 06/03/2009 | CN100493507C Application of compound 6-furfuryl amino purine in preparing medicine for treating female genital organ damage |
| 06/03/2009 | CN100493506C Application of compound 6-furfuryl amino purine in preparing medicine for treating brain tissue oxidizing damage |
| 06/03/2009 | CN100493505C Sustained release formulation with cetirizine and pseudoephedrine hydronate |
| 06/03/2009 | CN100493504C Sustained-release microsphere of kukoline or its salts and preparation thereof and sustained-release injection preparations |
| 06/03/2009 | CN100493503C Taste masked dry suspension for treating infant cold and method for preparing same |
| 06/03/2009 | CN100493502C Method for preparing 'Fen Ma Mei Yu' dispersible tablet |
| 06/03/2009 | CN100493501C Scopolamine hydrobromide dry powder inhalant for nose and preparing method |
| 06/03/2009 | CN100493500C Application of 2, 2'-bipyridine N- oxide disulfide in the preparing of antiphlogistic medicine |
| 06/03/2009 | CN100493499C Method for preparing compound famotidine chewing tablet |
| 06/03/2009 | CN100493498C Application of piperlonguminine and dihydropiperlonguminine in the preparation of the medicine for curing senile dementia |
| 06/03/2009 | CN100493497C Solid self-micro emulsion containing jervic alcohol for antineoplastic medicine and its preparation method |
| 06/03/2009 | CN100493496C Method of preparing active medicinal matter of lignin from broad-leaved tree and its use |
| 06/03/2009 | CN100493486C Kit for pharmaceutical use |
| 06/02/2009 | US7541495 para-alkyl-substituted N-(4-hydroxy-3-methoxy-benzyl)-cinnamamides, pharmaceutical compositions and uses thereof |
| 06/02/2009 | US7541478 Coumarin derivative and use thereof |
| 06/02/2009 | US7541477 hormone inhibitor 5-(4-fluorophenyl)-N-{2-[isopropyl(methyl)amino]-1H-benzimidazol-6-yl}-2-pyridinecarboxamide; treating the disorders of cardiovascular system, nervous system, metabolic systems, reproductive system, respiratory system, digestive system |
| 06/02/2009 | US7541476 Radiolabeled astemizole and method of making |
| 06/02/2009 | US7541468 Process of preparing N-ureidoalkyl-piperidines |
| 06/02/2009 | US7541466 Tetrahydroisoquinoline derivatives for treating protein trafficking diseases |
| 06/02/2009 | US7541465 Substituted 2-aminoacetamides and the use thereof |
| 06/02/2009 | US7541464 7-azaindoles, pharmaceutical compositions and their therapeutic applications |
| 06/02/2009 | US7541463 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541445 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 06/02/2009 | US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 06/02/2009 | US7541385 Formoterol or derivative in water for long term storage stability; nebulized aerosol |
| 06/02/2009 | US7541384 by increasing the tap density of the mesalamine and, lowering the melting point of the suppository base provides increased comfort of use without a substantial adverse effect on its dissolution profile or its overall therapeutic efficacy; rectal use; for treating ulcerative colitis; dosage form |
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |